STOCK TITAN

[Form 4] International Business Machines Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 06/30/2025, IBM filed a Form 4 showing that director Andrew N. Liveris converted a portion of his board fees into 331 “Promised Fee Shares” under the company’s Deferred Compensation and Equity Award Plan. The transaction is coded "A" (acquisition) and carries a notional valuation reference of $294.78 per underlying share, but no cash was paid; the shares will be distributed only after the director retires. As a result, Liveris’ total beneficial ownership increases to 42,008 IBM common shares. The filing involves less than 0.0004 % of IBM’s ~920 million shares outstanding, entails no open-market activity, and has no immediate effect on share count, cash flow, or corporate control. Overall, the disclosure is a routine, compensation-related insider acquisition with negligible financial or strategic impact on the company.

Il 30/06/2025, IBM ha depositato un Modulo 4 che mostra come il direttore Andrew N. Liveris abbia convertito una parte dei suoi compensi da consiglio in 331 “Azioni Promesse come Compenso” nell'ambito del Piano di Retribuzione Differita e Premi Azionari della società. L'operazione è classificata come "A" (acquisizione) e ha un valore nominale di riferimento di 294,78 $ per azione sottostante, ma non è stato pagato alcun importo in contanti; le azioni saranno distribuite solo dopo il pensionamento del direttore. Di conseguenza, la proprietà effettiva totale di Liveris aumenta a 42.008 azioni ordinarie IBM. La comunicazione riguarda meno dello 0,0004% delle circa 920 milioni di azioni IBM in circolazione, non comporta attività sul mercato aperto e non ha effetti immediati sul numero di azioni, sul flusso di cassa o sul controllo societario. In generale, la divulgazione rappresenta un'acquisizione interna di routine legata alla retribuzione, con un impatto finanziario o strategico trascurabile per la società.

El 30/06/2025, IBM presentó un Formulario 4 que muestra que el director Andrew N. Liveris convirtió una parte de sus honorarios como miembro del consejo en 331 “Acciones Prometidas como Honorarios” bajo el Plan de Compensación Diferida y Premios de Capital de la empresa. La transacción está codificada como "A" (adquisición) y tiene un valor referencial nominal de $294.78 por acción subyacente, pero no se pagó efectivo; las acciones se distribuirán solo después de que el director se jubile. Como resultado, la propiedad beneficiaria total de Liveris aumenta a 42,008 acciones ordinarias de IBM. La presentación involucra menos del 0,0004 % de las aproximadamente 920 millones de acciones en circulación de IBM, no implica actividad en el mercado abierto y no tiene un efecto inmediato en el recuento de acciones, flujo de efectivo o control corporativo. En general, la divulgación es una adquisición interna rutinaria relacionada con la compensación, con un impacto financiero o estratégico insignificante para la empresa.

2025년 6월 30일, IBM은 이사 Andrew N. Liveris가 이사회 수수료의 일부를 회사의 연기 보상 및 주식 수여 계획에 따라 331주 “약속된 수수료 주식”으로 전환했음을 보여주는 양식 4를 제출했습니다. 거래는 "A"(취득)로 분류되며, 기초 주당 $294.78의 명목 가치 기준이 적용되었으나 현금 지급은 없었으며, 주식은 이사가 은퇴한 후에만 분배됩니다. 결과적으로 Liveris의 총 실질 소유 주식 수는 42,008주 IBM 보통주로 증가합니다. 이번 제출은 IBM의 약 9억 2천만 주 중 0.0004% 미만에 해당하며, 공개 시장에서의 거래는 없고 주식 수, 현금 흐름 및 기업 통제에 즉각적인 영향이 없습니다. 전반적으로 이번 공시는 보상과 관련된 일상적인 내부자 취득으로, 회사에 미미한 재무적 또는 전략적 영향을 미칩니다.

Le 30/06/2025, IBM a déposé un formulaire 4 indiquant que le directeur Andrew N. Liveris a converti une partie de ses honoraires de conseil en 331 « Actions Promises en Rémunération » dans le cadre du Plan de Compensation Différée et d'Attribution d'Actions de la société. La transaction est codée "A" (acquisition) et porte une valeur de référence notionnelle de 294,78 $ par action sous-jacente, mais aucun paiement en espèces n'a été effectué ; les actions ne seront distribuées qu'après la retraite du directeur. En conséquence, la propriété bénéficiaire totale de Liveris augmente à 42 008 actions ordinaires IBM. Le dépôt concerne moins de 0,0004 % des quelque 920 millions d'actions IBM en circulation, n'implique aucune activité sur le marché ouvert et n'a aucun effet immédiat sur le nombre d'actions, les flux de trésorerie ou le contrôle de l'entreprise. Dans l'ensemble, cette divulgation constitue une acquisition interne de routine liée à la rémunération, avec un impact financier ou stratégique négligeable pour la société.

Am 30.06.2025 reichte IBM ein Formular 4 ein, das zeigt, dass der Direktor Andrew N. Liveris einen Teil seiner Vergütungen aus dem Vorstand in 331 „Versprochene Gebühranteile“ im Rahmen des Deferred Compensation and Equity Award Plans des Unternehmens umgewandelt hat. Die Transaktion ist mit dem Code "A" (Erwerb) gekennzeichnet und hat einen notionalen Bewertungsreferenzwert von 294,78 $ pro zugrundeliegender Aktie, jedoch wurde kein Bargeld gezahlt; die Aktien werden erst nach dem Ruhestand des Direktors ausgegeben. Dadurch erhöht sich Liveris’ gesamtes wirtschaftliches Eigentum auf 42.008 IBM-Stammaktien. Die Meldung betrifft weniger als 0,0004 % der rund 920 Millionen ausstehenden IBM-Aktien, beinhaltet keine Aktivitäten am offenen Markt und hat keine unmittelbaren Auswirkungen auf die Aktienanzahl, den Cashflow oder die Unternehmensführung. Insgesamt handelt es sich um eine routinemäßige, vergütungsbezogene Insider-Erwerbung mit vernachlässigbarem finanziellen oder strategischen Einfluss auf das Unternehmen.

Positive
  • Director Andrew N. Liveris increased his IBM stake by 331 shares, reflecting continued alignment of board compensation with shareholder value.
Negative
  • None.

Insights

TL;DR Director adds 331 deferred shares; routine and immaterial for IBM valuation.

The reported acquisition stems from a recurring fee-deferral feature rather than discretionary insider buying. At roughly US$98 k in notional value and just 331 shares, the amount is trivial versus IBM’s market capitalization, offering no insight into operational momentum or future earnings. Because the Promised Fee Shares are not distributed until retirement, there is no near-term dilution or liquidity impact. I therefore classify the filing as neutral for investors—useful for governance tracking but not a catalyst for the stock.

Il 30/06/2025, IBM ha depositato un Modulo 4 che mostra come il direttore Andrew N. Liveris abbia convertito una parte dei suoi compensi da consiglio in 331 “Azioni Promesse come Compenso” nell'ambito del Piano di Retribuzione Differita e Premi Azionari della società. L'operazione è classificata come "A" (acquisizione) e ha un valore nominale di riferimento di 294,78 $ per azione sottostante, ma non è stato pagato alcun importo in contanti; le azioni saranno distribuite solo dopo il pensionamento del direttore. Di conseguenza, la proprietà effettiva totale di Liveris aumenta a 42.008 azioni ordinarie IBM. La comunicazione riguarda meno dello 0,0004% delle circa 920 milioni di azioni IBM in circolazione, non comporta attività sul mercato aperto e non ha effetti immediati sul numero di azioni, sul flusso di cassa o sul controllo societario. In generale, la divulgazione rappresenta un'acquisizione interna di routine legata alla retribuzione, con un impatto finanziario o strategico trascurabile per la società.

El 30/06/2025, IBM presentó un Formulario 4 que muestra que el director Andrew N. Liveris convirtió una parte de sus honorarios como miembro del consejo en 331 “Acciones Prometidas como Honorarios” bajo el Plan de Compensación Diferida y Premios de Capital de la empresa. La transacción está codificada como "A" (adquisición) y tiene un valor referencial nominal de $294.78 por acción subyacente, pero no se pagó efectivo; las acciones se distribuirán solo después de que el director se jubile. Como resultado, la propiedad beneficiaria total de Liveris aumenta a 42,008 acciones ordinarias de IBM. La presentación involucra menos del 0,0004 % de las aproximadamente 920 millones de acciones en circulación de IBM, no implica actividad en el mercado abierto y no tiene un efecto inmediato en el recuento de acciones, flujo de efectivo o control corporativo. En general, la divulgación es una adquisición interna rutinaria relacionada con la compensación, con un impacto financiero o estratégico insignificante para la empresa.

2025년 6월 30일, IBM은 이사 Andrew N. Liveris가 이사회 수수료의 일부를 회사의 연기 보상 및 주식 수여 계획에 따라 331주 “약속된 수수료 주식”으로 전환했음을 보여주는 양식 4를 제출했습니다. 거래는 "A"(취득)로 분류되며, 기초 주당 $294.78의 명목 가치 기준이 적용되었으나 현금 지급은 없었으며, 주식은 이사가 은퇴한 후에만 분배됩니다. 결과적으로 Liveris의 총 실질 소유 주식 수는 42,008주 IBM 보통주로 증가합니다. 이번 제출은 IBM의 약 9억 2천만 주 중 0.0004% 미만에 해당하며, 공개 시장에서의 거래는 없고 주식 수, 현금 흐름 및 기업 통제에 즉각적인 영향이 없습니다. 전반적으로 이번 공시는 보상과 관련된 일상적인 내부자 취득으로, 회사에 미미한 재무적 또는 전략적 영향을 미칩니다.

Le 30/06/2025, IBM a déposé un formulaire 4 indiquant que le directeur Andrew N. Liveris a converti une partie de ses honoraires de conseil en 331 « Actions Promises en Rémunération » dans le cadre du Plan de Compensation Différée et d'Attribution d'Actions de la société. La transaction est codée "A" (acquisition) et porte une valeur de référence notionnelle de 294,78 $ par action sous-jacente, mais aucun paiement en espèces n'a été effectué ; les actions ne seront distribuées qu'après la retraite du directeur. En conséquence, la propriété bénéficiaire totale de Liveris augmente à 42 008 actions ordinaires IBM. Le dépôt concerne moins de 0,0004 % des quelque 920 millions d'actions IBM en circulation, n'implique aucune activité sur le marché ouvert et n'a aucun effet immédiat sur le nombre d'actions, les flux de trésorerie ou le contrôle de l'entreprise. Dans l'ensemble, cette divulgation constitue une acquisition interne de routine liée à la rémunération, avec un impact financier ou stratégique négligeable pour la société.

Am 30.06.2025 reichte IBM ein Formular 4 ein, das zeigt, dass der Direktor Andrew N. Liveris einen Teil seiner Vergütungen aus dem Vorstand in 331 „Versprochene Gebühranteile“ im Rahmen des Deferred Compensation and Equity Award Plans des Unternehmens umgewandelt hat. Die Transaktion ist mit dem Code "A" (Erwerb) gekennzeichnet und hat einen notionalen Bewertungsreferenzwert von 294,78 $ pro zugrundeliegender Aktie, jedoch wurde kein Bargeld gezahlt; die Aktien werden erst nach dem Ruhestand des Direktors ausgegeben. Dadurch erhöht sich Liveris’ gesamtes wirtschaftliches Eigentum auf 42.008 IBM-Stammaktien. Die Meldung betrifft weniger als 0,0004 % der rund 920 Millionen ausstehenden IBM-Aktien, beinhaltet keine Aktivitäten am offenen Markt und hat keine unmittelbaren Auswirkungen auf die Aktienanzahl, den Cashflow oder die Unternehmensführung. Insgesamt handelt es sich um eine routinemäßige, vergütungsbezogene Insider-Erwerbung mit vernachlässigbarem finanziellen oder strategischen Einfluss auf das Unternehmen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LIVERIS ANDREW N

(Last) (First) (Middle)
C/O SECRETARY'S OFFICE, IBM CORPORATION
ONE NEW ORCHARD ROAD

(Street)
ARMONK NY 10504

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL BUSINESS MACHINES CORP [ IBM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Promised Fee Share $0.00(1) 06/30/2025 A(2) 331 (3) (3) Common Stock 331 $294.78 42,008 D
Explanation of Responses:
1. Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.
2. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.
3. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.
Remarks:
L. Mallardi on behalf of A. N. Liveris 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IBM shares did Director Andrew N. Liveris acquire on 06/30/2025?

He acquired 331 Promised Fee Shares through fee deferral.

What is a Promised Fee Share in IBM’s Deferred Compensation and Equity Award Plan?

It is a bookkeeping unit that tracks IBM common stock and is paid out in stock or cash after a director retires.

How many IBM shares does Andrew N. Liveris now beneficially own?

Following the transaction, he beneficially owns 42,008 shares.

Does the Form 4 show any sale of IBM shares by the director?

No. The filing lists only an acquisition; no shares were sold or disposed of.

Is this transaction part of a 10b5-1 trading plan?

The form does not indicate a 10b5-1 plan; it is a routine fee-deferral election.

Will the newly acquired shares impact IBM’s share count immediately?

No. Distribution of the Promised Fee Shares is deferred until the director retires, so there is no immediate dilution.
International Business Machines Corp

NYSE:IBM

IBM Rankings

IBM Latest News

IBM Latest SEC Filings

IBM Stock Data

270.64B
928.18M
0.13%
64.17%
1.83%
Information Technology Services
Computer & Office Equipment
Link
United States
ARMONK